KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 90 filers reported holding KALVISTA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,258,938 | +22.6% | 234,573 | +14.6% | 1.83% | +55.3% |
| Q2 2023 | $1,842,480 | +197.8% | 204,720 | +160.1% | 1.18% | +179.8% |
| Q1 2023 | $618,739 | +16.3% | 78,720 | 0.0% | 0.42% | +14.7% |
| Q4 2022 | $532,147 | -53.4% | 78,720 | 0.0% | 0.37% | -49.7% |
| Q3 2022 | $1,142,000 | +47.4% | 78,720 | 0.0% | 0.73% | +37.0% |
| Q2 2022 | $775,000 | -33.2% | 78,720 | 0.0% | 0.53% | -3.3% |
| Q1 2022 | $1,160,000 | +11.4% | 78,720 | 0.0% | 0.55% | +78.6% |
| Q4 2021 | $1,041,000 | -24.2% | 78,720 | 0.0% | 0.31% | -30.0% |
| Q3 2021 | $1,374,000 | -27.1% | 78,720 | 0.0% | 0.44% | -24.9% |
| Q2 2021 | $1,886,000 | – | 78,720 | – | 0.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $25,679,000 | 12.37% |
| Vivo Capital, LLC | 1,618,296 | $30,731,000 | 1.37% |
| Opaleye Management Inc. | 470,203 | $8,929,000 | 1.17% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $7,383,000 | 0.92% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 177,433 | $3,369,000 | 0.92% |
| Ikarian Capital, LLC | 1,063,961 | $20,204,000 | 0.89% |
| Ghost Tree Capital, LLC | 200,000 | $3,798,000 | 0.85% |
| Logos Global Management LP | 490,000 | $9,305,000 | 0.80% |
| Eventide Asset Management | 1,680,000 | $31,903,000 | 0.49% |
| Affinity Asset Advisors, LLC | 45,000 | $855,000 | 0.45% |